Table 1. Early-Stage Favorable-Risk Outcomes

EFS MOPP-ABV plus IFRT (95% CI) STNI (95% CI) P value

5-year 98% (96%–99%) 74% (68%–79%) <0.001
10-year 93% (85%–97%) 68% (64%–76%) <0.001